Copy to clipboard 
Orthofix Medical commenced U.S. commercial launch of the Fitbone Trochanteric Lengthening System, expanding the Fitbone internal limb lengthening portfolio. This latest addition introduces a trochanteric entry option designed to support both adult and pediatric patients and broaden the clinical possibilities in modern limb reconstruction.
The system presents a fully implantable solution for femoral lengthening that supports a bone‑conserving, minimally invasive approach. Featuring the smallest proximal diameter currently available, it offers an advancement for treating pediatric and small‑stature patients (ages 12–21) who require a safer entry point through the greater trochanter.
The trochanteric entry configuration adds versatility to the Fitbone portfolio with:
- Smaller diameter options to support pediatric and small stature patients
- Extended lengthening ranges that broaden treatment possibilities
- Purpose‑designed instrumentation for limb alignment and soft tissue protection
- Trial nails that assist with safe trajectory assessment and blocking screw placement
With an antegrade approach through the greater trochanter, the new design provides an entry point that aligns well with the anatomical requirements of smaller femoral canals—an essential consideration for younger or small stature individuals.
The trochanteric option complements existing Fitbone solutions, including the Fitbone TAA Femoral and Tibial Nails and the Fitbone Transport and Lengthening System, used for treating bone defects arising from trauma, infection, or tumor‑related conditions
Source: Orthofix Medical
